UCSF School of Pharmacy’s 32nd year of top NIH funding includes many new projects

For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

Total grants and contracts awarded to School of Pharmacy researchers during the NIH fiscal year 2011 (running from October 1, 2010 to September 31, 2011) totaled $29.1 million, according to Michael Nordberg, MPA/HSA, associate dean of administration and finance.

Such preeminence in securing highly competitive U.S. federal research funds reflects the School’s strengths in advancing long-standing national technology centers in mass spectrometry and biocomputing, as well as on-going major research projects within the School’s three departments, including areas such as:

• Women and HIV, Department of Clinical Pharmacy.
• Pharmacogenomics of membrane transporters, Department of Bioengineering and Therapeutic Sciences.
• Key enzymes in apoptosis and inflammation, Department of Pharmaceutical Chemistry.

But the School’s continuing leadership also reflects first-time NIH support for new faculty projects as well as for new researchers, including two postdoctoral fellows.

More on new NIH funding

• New NIH funding awarded to UCSF School of Pharmacy postdoctoral fellows in 2011
• New NIH funding awarded to the Department of Pharmaceutical Chemistry in 2011
• New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011
• New NIH funding awarded to the Department of Clinical Pharmacy in 2011

School of Pharmacy NIH funding

This chart shows grants and contracts by fiscal year increasing from $19 million in 2002 to $29 million in 2011, peaking in 2010 at slightly over $30 million. Source: American Association of Colleges of Pharmacy (2002-2010), internal (2011).